Statin usage and all-cause and disease-specific mortality in a nationwide study

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 1, 2012, Pages 61-69

  Haukka, Jari ^a,c   Niskanen, Leo ^b   Partonen, Timo ^c   Lönnqvist, Jouko ^c   Tiihonen, Jari ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Mortality; Pharmacoepidemiology; Statins

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG FATALITY; DRUG USE; DRUG UTILIZATION; FEMALE; FINLAND; FOLLOW UP; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PATIENT COMPLIANCE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; STROKE; SUICIDE ATTEMPT;

AGED; CORONARY DISEASE; DATABASES, FACTUAL; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICAL RECORD LINKAGE; MEDICATION ADHERENCE; MIDDLE AGED; NEOPLASMS; STROKE; SUICIDE; TIME FACTORS;

EID: 84855398968     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2255     Document Type: Article

References (20)

1. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 2005 Oct; 366(9493): 1267-78.[cited 2008 Dec 23]
2. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008 Jan; 371(9607): 117-125.
3. Drug consumption in 2005-2008 in Finland [Internet]. [date unknown];[cited 2009 Jul 28] Available from:
4. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003 Jun; 361(9374): 2005-2016. [cited 2008 Dec 23]
5. Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009 Jun; 338(jun30-1): b2376.[cited 2009 Aug 10]
6. Shepherd J, Cobbe SM, Ford I, et al. The West of Scotland coronary prevention study group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995 Nov; 333(20): 1301-1308.[cited 2008 Dec 23]
7. Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD. Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med 2009 Feb; 169(3): 260-268.[cited 2009 Aug 10]
8. Hippisley-Cox J, Coupland C. Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis. Heart 2006 Jun; 92(6): 752-758.[cited 2009 Sep 2]
9. Anker SD, Clark AL, Winkler R, et al. Statin use and survival in patients with chronic heart failure -- results from two observational studies with 5200 patients. Int J Cardiol 2006 Sep; 112(2): 234-242.[cited 2009 Sep 2]
10. Davidson M. Differences between clinical trial efficacy and real-world effectiveness. Am J Manag Care 2005; 12: S405-S411.
11. Alemao E, Yin D, Sintonen H, Salomaa V, Jousilahti P. Evaluation of lipid-lowering therapy and cholesterol goal attainment in Finland: the National FINRSK study. J Cardiovasc Drugs 2006 2006; 6(5): 349-355.
12. Dale KM, Coleman CI, Henyan NN, Kluger J, White CM. Statins and cancer risk: a meta-analysis. JAMA 2006 Jan; 295(1): 74-80.[cited 2008 Dec 19]
13. Browning DRL, Martin RM. Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer 2007; 120(4): 833-843.[cited 2008 Dec 19]
14. Kuoppala J, Lamminpää A, Pukkala E. Statins and cancer: a systematic review and meta-analysis. Eur J Cancer 2008 Oct; 44(15): 2122-2132.[cited 2008 Dec 23]
15. Partonen T, Haukka J, Virtamo J, Taylor PR, Lönnqvist J. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry 1999 Sep; 175: 259-262.[cited 2009 Aug 17]
16. Lalovic A, Klempan T, Sequeira A, Luheshi G, Turecki G. Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers. J Affect Disord 2010 Jan; 120(1-3): 24-31.[cited 2010 Feb 22]
17. Haukka J, Sankila R, Klaukka T, et al. Incidence of cancer and statin usage - record linkage study. Int J Cancer 2010 Jan; 126(1): 279-284.[cited 2010 Sep 13]
18. Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology November 2001; 12(6): 682-689.
19. Helin-Salmivaara A, Lavikainen P, Korhonen MJ, et al. Long-term persistence with statin therapy: a nationwide register study in Finland. Clin Ther 2008; 30(Part 2): 2228-2240.[cited 2010 Feb 3]
20. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology September 2000; 11(5): 561-570.